Work

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Year: 2021

Type: article

Abstract: ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.21.02677

Authors: Sharon H. Giordano, Rachel A. Freedman, Mark R. Somerfield, for the Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Expert Panel

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, American Society of Clinical Oncology

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: American Society of Clinical Oncology